Cargando…
Are proton pump inhibitors the first choice for acute treatment of gastric ulcers? A meta analysis of randomized clinical trials
BACKGROUND: Gastric ulcers are a frequent problem in the United States. Proton pump inhibitors have been shown to increase healing rates and improve clinical symptoms. The objective of this study is to compare gastric ulcer healing rates for patients treated with a proton pump inhibitor (PPI) (omepr...
Autores principales: | Salas, Maribel, Ward, Alexandra, Caro, Jaime |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2002
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC117603/ https://www.ncbi.nlm.nih.gov/pubmed/12119060 http://dx.doi.org/10.1186/1471-230X-2-17 |
Ejemplares similares
-
Rebamipide Plus Proton Pump Inhibitor Versus Proton Pump Inhibitor Alone in the Treatment of Endoscopic Submucosal Dissection-Induced Gastric Ulcer: Retracted: A Meta-Analysis of Randomized Controlled Trials
por: Xiong, Ji, et al.
Publicado: (2014) -
Effect of a Proton Pump Inhibitor on the Duodenum Microbiome of Gastric Ulcer Patients
por: Lim, Jung-Hyun, et al.
Publicado: (2022) -
Notice of Retraction: Rebamipide plus proton pump inhibitor versus proton
pump inhibitor alone in treatment of endoscopic submucosal dissection-induced gastric
ulcer: a meta-analysis of randomized controlled trials
Publicado: (2014) -
A146 BENIGN GASTRIC ULCER COMPLICATED BY GASTROJEJUNAL FISTULA FORMATION HEALED WITH PROTON-PUMP INHIBITOR
por: Winter, R, et al.
Publicado: (2023) -
Efficacy of Proton Pump Inhibitors for Patients with Duodenal Ulcers: A Pairwise and Network Meta-Analysis of Randomized Controlled Trials
por: Hu, Zhan-Hong, et al.
Publicado: (2017)